Product descriptionBTT-3033 is an orally active conformation-selective inhibitor of α2β1 (EC50: 130 nM) by binding to the α2I domain. BTT-3033 inhibits platelet binding to collagen Ⅰ and cell proliferation, and induces cell apoptosis. BTT-3033 can be used in the research of prostate cancer, inflammation and cardiovascular disease.
Specifications and Purity: ≥98%(HPLC)
MDL Number: MFCD28166480
Molecular Formula: C23H20FN5O3S
Molecular Weight: 465.5
PubChem CID: 49841251
Isomeric SMILES: CN(C1=CC=C(C=C1)NC(=O)NC2=CC=CC=C2)S(=O)(=O)C3=CN(N=C3)C4=CC=C(C=C4)F
Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/B288291-SCI_4de4aef766d33686621d77d5046a33a3.pdf
- UPC:
- 12141752
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- B288291-50mg
- CAS:
- 1259028-99-3
- Product Size:
- 50mg
akash.verma@cenmed.com
(732) 447-1115





